wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55354182-4B8E0FDC-4EE5-40F1-862A-4BCA05D2F950
Q55354182-4B8E0FDC-4EE5-40F1-862A-4BCA05D2F950
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55354182-4B8E0FDC-4EE5-40F1-862A-4BCA05D2F950
Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.
P2860
Q55354182-4B8E0FDC-4EE5-40F1-862A-4BCA05D2F950
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55354182-4B8E0FDC-4EE5-40F1-862A-4BCA05D2F950
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
28dc0a8a5c9a605bdff0adf72ea0b910eac71ba2
P2860
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.